Homework Help is Here – Start Your Trial Now!
Business
Finance
Discuss the process of determining the fair value of the asset acquired from VLB as prescribed by MFRS 13 Fair Value Measurement.

Discuss the process of determining the fair value of the asset acquired from VLB as prescribed by MFRS 13 Fair Value Measurement.

Essentials Of Investments
Essentials Of Investments
11th Edition
ISBN:9781260013924
Author:Bodie, Zvi, Kane, Alex, MARCUS, Alan J.
Publisher:Bodie, Zvi, Kane, Alex, MARCUS, Alan J.
Chapter1: Investments: Background And Issues
Section: Chapter Questions
Problem 1PS
See similar textbooks
icon
Related questions
Question

Required:

  • Discuss the process of determining the fair value of the asset acquired from VLB as prescribed by MFRS 13 Fair Value Measurement.
Gramax Health Bhd (GHB), a company operates in a health industry, is working in a project to develop a test kit that is able to determine the level of immunity a person has towards Covid- 19 based on his or her antibodies with higher accuracy rate compared with other similar test kits that are available in the market. In a recent business combination, GHB acquires a research and development (R&D) project of Vital Life Bhd (VLB) to develop a similar test kit with the one it develops. GHB does not intend to complete the project that had been acquired as it would compete with its own project. Its main intention to acquire the project is to prevent its competitors from obtaining access to the technology. Meanwhile, as part of its effort to fund its R&D projects, on 31 December 2019 GHB issued at par in a private placement a RM3 million 5-year fixed rate bond with an annual 10% interest coupon rate. On 31 December 2020, GHB's credit spread has deteriorated due to a change in its non-performance risk. If the bond was issued on 31 December 2020, the instrument would need to have an interest rate of 11%. In reducing its reliance on third party service, GHB also plans to acquire Magnificent Sdn Bhd, a local transportation company. Magnificent Sdn Bhd's estimated cash flow (before tax) for the next four years are RM167,500, RM182,200, RM191,300, and RM198,300 with probability of attainment of the cash flows are 95% for the first two years and 85% afterwards. The cash flows of Magnificent Sdn Bhd beyond year four is expected to be indefinite. The estimated weighted average cost of capital for Magnificent Sdn Bhd is 9% although it is expected that an additional risks premium of 1% will be applicable to Magnificent Sdn Bhd due to its smaller size and unlisted status. GHB accounting year ends on 31 December.
Transcribed Image Text:Gramax Health Bhd (GHB), a company operates in a health industry, is working in a project to develop a test kit that is able to determine the level of immunity a person has towards Covid- 19 based on his or her antibodies with higher accuracy rate compared with other similar test kits that are available in the market. In a recent business combination, GHB acquires a research and development (R&D) project of Vital Life Bhd (VLB) to develop a similar test kit with the one it develops. GHB does not intend to complete the project that had been acquired as it would compete with its own project. Its main intention to acquire the project is to prevent its competitors from obtaining access to the technology. Meanwhile, as part of its effort to fund its R&D projects, on 31 December 2019 GHB issued at par in a private placement a RM3 million 5-year fixed rate bond with an annual 10% interest coupon rate. On 31 December 2020, GHB's credit spread has deteriorated due to a change in its non-performance risk. If the bond was issued on 31 December 2020, the instrument would need to have an interest rate of 11%. In reducing its reliance on third party service, GHB also plans to acquire Magnificent Sdn Bhd, a local transportation company. Magnificent Sdn Bhd's estimated cash flow (before tax) for the next four years are RM167,500, RM182,200, RM191,300, and RM198,300 with probability of attainment of the cash flows are 95% for the first two years and 85% afterwards. The cash flows of Magnificent Sdn Bhd beyond year four is expected to be indefinite. The estimated weighted average cost of capital for Magnificent Sdn Bhd is 9% although it is expected that an additional risks premium of 1% will be applicable to Magnificent Sdn Bhd due to its smaller size and unlisted status. GHB accounting year ends on 31 December.
Expert Solution
steps

Step by step

Solved in 2 steps

SEE SOLUTIONCheck out a sample Q&A here
Blurred answer
Knowledge Booster
Liquidity Risk
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, finance and related others by exploring similar questions and additional content below.
Similar questions
Recommended textbooks for you
Essentials Of Investments
Essentials Of Investments
Finance
ISBN:
9781260013924
Author:
Bodie, Zvi, Kane, Alex, MARCUS, Alan J.
Publisher:
Mcgraw-hill Education,
FUNDAMENTALS OF CORPORATE FINANCE
FUNDAMENTALS OF CORPORATE FINANCE
Finance
ISBN:
9781260013962
Author:
BREALEY
Publisher:
RENT MCG
Financial Management: Theory & Practice
Financial Management: Theory & Practice
Finance
ISBN:
9781337909730
Author:
Brigham
Publisher:
Cengage
Foundations Of Finance
Foundations Of Finance
Finance
ISBN:
9780134897264
Author:
KEOWN, Arthur J., Martin, John D., PETTY, J. William
Publisher:
Pearson,
Fundamentals of Financial Management (MindTap Cou…
Fundamentals of Financial Management (MindTap Cou…
Finance
ISBN:
9781337395250
Author:
Eugene F. Brigham, Joel F. Houston
Publisher:
Cengage Learning
Corporate Finance (The Mcgraw-hill/Irwin Series i…
Corporate Finance (The Mcgraw-hill/Irwin Series i…
Finance
ISBN:
9780077861759
Author:
Stephen A. Ross Franco Modigliani Professor of Financial Economics Professor, Randolph W Westerfield Robert R. Dockson Deans Chair in Bus. Admin., Jeffrey Jaffe, Bradford D Jordan Professor
Publisher:
McGraw-Hill Education
SEE MORE TEXTBOOKS